.AstraZeneca has discussed an early examine the efficiency of its own internal antibody-drug conjuga...
.After revealing a phase 3 launch based upon beneficial midstage end results, iTeos and also GSK are...
.The FDA must be actually much more open and collective to release a rise in approvals of uncommon i...
.It is actually an extraordinarily busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicar...
.Atea Pharmaceuticals' antiviral has actually failed yet another COVID-19 test, yet the biotech stil...
.Neurocrine Biosciences' mental illness plan pivot has actually stopped working. The biotech was inc...
.Sanofi has actually brought in a late access to the radioligand celebration, paying for 100 thousan...
.After F2G's very first try to obtain a new training class of antifungal to market was actually wrec...
.Moderna has actually sworn to reduce R&D investing by $1.1 billion through 2027. The selection t...
.Merely four months after Sanofi wager $80 million in upfront cash on Key Rehabs' losmapimod, the pr...